- Rediscovery of NF‐κB signaling in nasopharyngeal carcinoma: How genetic defects of NF‐κB pathway interplay with EBV in driving oncogenesis?
Mei Yi et al, 2018, Journal of Cellular Physiology CrossRef - Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis
Youwen Zhu et al, 2022, Frontiers in Pharmacology CrossRef - The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
Zi-Lu Huang et al, 2019, Cancer Cell International CrossRef - Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
Shin Hye Yoo et al, 2019, Scientific Reports CrossRef - The Prognostic Role of Programmed Death‐Ligand 1 in Nasopharyngeal Carcinoma
Michael Wotman et al, 2020, The Laryngoscope CrossRef - Analysis of Epstein–Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region
Josiane M. Dias et al, 2022, International Journal of Molecular Sciences CrossRef - Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
Pui Yan Siak et al, 2023, Journal of Translational Medicine CrossRef - Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma
David Johnson et al, 2021, Oral Oncology CrossRef - Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma
Mona M. Ahmed et al, 2021, Applied Immunohistochemistry & Molecular Morphology CrossRef - A Clinical-Radiomics Nomogram Based on Computed Tomography for Predicting Risk of Local Recurrence After Radiotherapy in Nasopharyngeal Carcinoma
Chaohua Zhu et al, 2021, Frontiers in Oncology CrossRef - Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer
Fengge Zhou et al, 2022, Frontiers in Immunology CrossRef - Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis
Yi-Qun Jia et al, 2019, Aging CrossRef - Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
Siqing Jiang et al, 2022, Frontiers in Immunology CrossRef - Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma
Ju Zhao et al, 2022, Scientific Reports CrossRef - Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma
Yuan Qu et al, 2018, Molecular and Clinical Oncology CrossRef - Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients
Xiaofeng Liu et al, 2019, Frontiers in Oncology CrossRef - Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma
Yabing Cao et al, 2019, BMC Cancer CrossRef - Low PD-L1 Expression Strongly Correlates with Local Recurrence in Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma after Radiation-Based Therapy
Yu-Jen Liu et al, 2018, Cancers CrossRef - Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma
Noppadol Larbcharoensub et al, 2018, American Journal of Clinical Oncology CrossRef - The Three P’s: Parotid, PD-L1, and Pembrolizumab
Amanda Wiggins et al, 2019, Case Reports in Oncological Medicine CrossRef - The Prognostic Significance of APOBEC3B and PD-L1/PD-1 in Nasopharyngeal Carcinoma
ChangYin Feng et al, 2021, Applied Immunohistochemistry & Molecular Morphology CrossRef - Cancer Immunotherapy for Nasopharyngeal Carcinoma
Dora L.W. Kwong et al, 2019, Nasopharyngeal Carcinoma CrossRef